ArticleInternational journal of general medicine2022

CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma.

Zhou Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.